Skip to main content

Table 1 Baseline characteristics of acute and chronic start patients

From: The impact of an “acute dialysis start” on the mortality attributed to the use of central venous catheters: a retrospective cohort study

 

Acute Start (n = 57)

Chronic Start (n = 349)

P

Age at dialysis start, years, (mean ± SD)

71 ± 12.0

62 ± 16

<0.001

Male gender, n (%)

32 (57)

202 (58)

0.89

Caucasian race, n (%)

50 (88)

323 (93)

0.20

Dialysis Access, n (%)

CVC

56 (98)

182 (52)

<0.001

AVF

1 (2)

95 (27)

<0.001

PD catheter

0

72 (21)

<0.001

Cause of ESRD, n (%)

Diabetes

8 (14)

110 (32)

0.007

Polycystic kidney disease

2 (4)

30 (9)

0.29

Glomerulonephritis

10 (18)

44 (13)

0.53

Referral time before dialysis start, days, (median, IQR)

3, 1 to 33

1087, 443 to 2571

<0.001

Referral < 3 months, n (%)

47 (82)

34 (10)

<0.001

Comorbidity

CCI (median, IQR)

5, 3 to 7

4, 2 to 6

0.03

Diabetes, n (%)

23 (41)

154 (44)

0.38

Coronary artery disease, n (%)

15 (27)

100 (29)

0.73

Congestive heart failure, n (%)

17 (30)

77 (22)

0.18

Peripheral vascular disease n (%)

14 (25)

78 (22)

0.73

Malignancya, n (%)

17 (30)

34 (10)

<0.001

Laboratory Values

Hemoglobin, g/L, (mean ± SD)

93 ± 15

100 ± 17

0.004

Albumin, g/L, (median, IQR)

26, 23 to 30

33, 28 to 36

<0.001

Phosphate, mmol/L, (median, IQR)

1.9, 1.4 to 2.6

1.8, 1.5 to 2.2

0.33

Imputed phosphateb

1.9, 1.5 to 2.6

1.9, 1.5 to 2.6

0.26

eGFR, ml/min/1.73 m2, (median, IQR)

6.8, 5.0 to 9.0

7.8, 6.0 to 10

0.01

Imputed eGFRc

6.8, 5.0 to 9.0

7.8, 6.0 to 10

0.01

  1. a: Including hematologic or non-hematologic, excluding non-melanoma skin cancer.
  2. b: 31 missing values imputed.
  3. c: 3 missing values imputed.